Blueprint Medicines Corporation (BPMC) Social Stream



Blueprint Medicines Corporation (BPMC): $48.93

1.44 (+3.03%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BPMC to Watchlist
Sign Up

Industry: Biotech


Ranked

of 381

in industry

BLUEPRINT MEDICINES CORP (BPMC) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering BLUEPRINT MEDICINES CORP.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 9 $136 $84 $113.222 $43.2 162.09%
2021-11-10 9 $136 $84 $114.444 $43.2 164.92%
2021-11-19 9 $136 $84 $115.777 $43.2 168%
2021-11-29 9 $136 $84 $115.555 $43.2 167.49%
2022-01-12 9 $135 $84 $113.333 $43.2 162.34%
2022-01-25 9 $135 $84 $110.555 $43.2 155.91%
2022-01-31 9 $135 $84 $108.444 $43.2 151.03%
2022-02-08 9 $135 $84 $104.777 $43.2 142.54%
2022-02-17 9 $133 $82 $100.625 $43.2 132.93%
2022-03-01 10 $133 $71 $97.333 $43.2 125.31%
2022-04-12 10 $133 $71 $97.888 $43.2 126.59%
2022-04-28 10 $133 $68 $97.555 $43.2 125.82%
2022-05-04 10 $133 $68 $96.7 $43.2 123.84%
2022-05-18 10 $152 $65 $100.272 $43.2 132.11%
2022-06-01 10 $152 $65 $99.363 $43.2 130.01%
2022-06-10 10 $152 $41 $96.909 $43.2 124.33%
2022-06-14 10 $152 $41 $92.454 $43.2 114.01%
2022-07-27 12 $152 $40 $86.461 $43.2 100.14%
2022-08-02 10 $152 $40 $86.461 $43.2 100.14%
2022-08-03 13 $152 $40 $86.23 $43.2 99.61%
2022-08-17 13 $152 $40 $88.214 $43.2 104.2%
2022-08-18 13 $152 $40 $87.285 $43.2 102.05%
2022-08-22 13 $152 $40 $87.714 $43.2 103.04%
2022-09-06 13 $152 $40 $88.428 $43.2 104.69%
2022-10-10 14 $152 $40 $89.533 $43.2 107.25%
2022-10-26 14 $152 $40 $89.8 $43.2 107.87%
2022-11-02 15 $152 $40 $85.133 $43.2 97.07%
2022-11-04 16 $115 $40 $78.733 $43.2 82.25%

The Trend in the Analyst Price Target


BPMC's average price target has moved down $40.96 over the prior 16 months.

BPMC reports an average of 54.57% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-31 9 135 84 108.444 77.10 40.65%
2022-03-22 10 133 71 97.888 66.50 47.2%
2022-05-04 10 133 68 97.000 63.26 53.34%
2022-08-18 13 152 40 87.285 64.09 36.19%
2022-09-06 13 152 40 88.428 70.66 25.15%

BPMC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.13 9 0 5 2 2 16

The Trend in the Broker Recommendations


BPMC's average broker recommendation rating improved by 0.07 over the prior 123 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, BLUEPRINT MEDICINES CORP's average analyst price target is higher than 2731.7% of them.
  • BPMC has a greater number of analysts covering the stock than 2604.04% of stocks in the mid market cap category.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, BLUEPRINT MEDICINES CORP's variance in analysts' estimates is lower than -2348.54% of them.
  • In terms of how BLUEPRINT MEDICINES CORP fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 2409.07% of that group.

Stocks similar to BLUEPRINT MEDICINES CORP in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MCRB, SIOX, and ASND.

Is BPMC a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6058 seconds.